top of page
Cancer Vaccine Institute News


HER2 ICD vaccine trial findings featured on KIRO7 news
CVI's Executive Director Dr. Kiran Dhillon spoke with KIRO7 news anchors Monique Ming Laven and Gary Horcher about our recent publication...

Kiran Dhillon
Nov 21, 2022


Breast Cancer Research Foundation funds CVI research on adipose-directed vaccine
We're grateful to the Breast Cancer Research Foundation for supporting our work in developing a vaccine that targets inflammation from...

Kiran Dhillon
Nov 21, 2022


KOMO4 News features CVI HER2 ICD DNA vaccine Phase I clinical trial
CVI Director Dr. Nora Disis spoke with Karina Vargas from KOMO4 news about the findings of our Phase I clinical trial with a HER2 ICD DNA...

Kiran Dhillon
Nov 21, 2022


HER2 ICD DNA vaccine study featured on Good Morning America & ABC News
We're excited to see the findings from our recent publication in JAMA Oncology describing our Phase I clinical trial with the HER2 ICD...

Kiran Dhillon
Nov 21, 2022


Dr. Disis shares the promise of cancer vaccines in interview with KUOW NPR
Check out CVI's Dr. Nora Disis' interview with KUOW NPR on the exciting prospects of cancer vaccines for therapy, cancer interception and...

Kiran Dhillon
Oct 17, 2022
Blog: Blog2
bottom of page
